TuHURA Biosciences, Inc./NV (HURA) stock
HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.37−0.03 (-2.14%)
Close on Nov 18, 2026Market cap $87.31MP/E –Yield –
TuHURA Biosciences ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for TuHURA Biosciences
TuHURA Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?